申请人:Tung Roger
公开号:US20080103154A1
公开(公告)日:2008-05-01
The present invention relates to novel 3,4-dihydro-2(1H)-quinolinone and 2(1H)-quinolinone derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by atypical antipsychotic agents. The invention further provides methods for using a compound of this invention to determine concentrations of a corresponding 3,4-dihydro-2(1H)-quinolinone or 2(1H)-quinolinone compound, particularly in biological fluids, and to determine metabolism patterns of that 3,4-dihydro-2(1H)-quinolinone or 2(1H)-quinolinone compound.
本发明涉及新颖的3,4-二氢-2(1H)-喹啉酮和2(1H)-喹啉酮衍生物,它们的可接受酸盐、溶剂化合物、水合物和多晶体。本发明还提供了包含该发明化合物的组合物,并将这些组合物用于治疗通过非典型抗精神病药物有益治疗的疾病和症状的方法。本发明还提供了使用本发明化合物测定相应的3,4-二氢-2(1H)-喹啉酮或2(1H)-喹啉酮化合物的浓度,特别是在生物液体中,以及确定该3,4-二氢-2(1H)-喹啉酮或2(1H)-喹啉酮化合物的代谢模式的方法。